Download the flyer.
Join Kathryn A. Cunningham from the University of Texas Medical Branch in Galveston as she highlights her team’s efforts in defining biobehavioral signatures for substance use disorder phenotypes to ultimately improve diagnostics and therapeutics for these devastating disorders. This seminar is supported by the ASU Department of Psychology and the Biodesign Institute.
Seminar: Biobehavioral signatures of substance use disorders
Presented by Kathryn A. Cunningham, Chauncey Leake Distinguished Professor of Pharmacology, Vice Chairman of the Department of Pharmacology and Toxicology, University of Texas Medical Branch at Galveston
Wednesday, September 23, 2020
Noon–1:30 p.m.
Attend this event on Zoom
Abstract
The abuse of psychoactive drugs in the U.S. is at epidemic proportions with drug overdose deaths at an all-time high. Vulnerability to drug misuse and the development of a substance use disorder is rooted within the interplay of genetic and environmental backgrounds, but also includes the biological impact of the abused drug. Individual differences in the intricate interplay of these factors present a barrier to effective treatment.
About the speaker
Kathryn A. Cunningham is the Chauncey Leake Distinguished Professor of Pharmacology, director of the Center for Addiction Research and vice chair of the Department of Pharmacology and Toxicology at the University of Texas Medical Branch in Galveston, Texas. She is a translational scientist with strong collaborations with chemists, cellular biologists, bioengineers, preclinical and clinical scientists with the goal to discover key neuromolecular targets that may be exploited toward the goal of improved diagnostics and therapeutics for substance use disorders.
